Web
Site
Search
Persondatapolitik
Personal data
Privacy policy
Vacancies
About us
About
Organisation
Staff
Contact Us
Om CHIP (Danish)
Links
Annual Reports
Privacy Policy
Research
Studies
CARE
Study Documents
Presentations
Publications
COVID-19
ACTT Study
Publications
CATCH
ITAC Study
TESICO Study
TICO Study
Publications
OTAC Study
VATICO Study
D:A:D
About
Meetings
Newsletters
Position Statement
Presentations
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
Publications
2021
2020
2019
2018
2017
2016
2015
2014
2003-2013
Study Documents
Study Group
Submit research concept
EuroSIDA
About
Newsletters
2024
2023
2022
2021
2020
2017
2016
2015
2014
2013
2012
2011
Samples
Study documents
Study group
Contacts
RESPOND
Submit proposal
Publications
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2006-2011
1997-2005
AIDS in Europe
Tracking HIV/AIDS
EuroSIDA a multicenter study, 1994-2009
Presentations
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Influenza
Data Protection
FLU 003 Plus
FLU-IVIG
Genomics
MISTRAL
About MISTRAL
Study documents
Patient Instructions & Bristol Scale
Study group
Samples
MISTRAL Presentations
MISTRAL Newsletters
Frequently asked questions (FAQ)
Contact
PrEPaRe
Patient questionnaire
PreVent-ACaLL
Study documents
RESPOND
About
Meetings
2024
2023
2022
2021
2020
2019
2018
Study documents
Study group
SIGs
Hepatitis/Viral co-infection
Outcomes ARVs
Gender Specific Outcomes
Tuberculosis
Public Health
ESTIHIV
Submit proposal
Publications
2024
2023
2022
2021
2020
Presentations
2024
2023
2022
2021
2020
2019
Newsletters
Contact
Collaborating cohorts
AHIVCOS
AHOD
ATHENA
CHU Saint-Pierre
Croatian HIV cohort
University Hospital Cologne
University Hospital Bonn
EuroSIDA
Frankfurt HIV Cohort Study
Georgian National AIDS Health Information System
ICONA
Modena HIV Cohort
Nice HIV Cohort
PISCIS
SHCS
Swedish InfCare HIV Cohort
Royal Free HIV Cohort Study
San Raffaele Scientific Institute
Brighton HIV cohort
START
About
Data Protection
Completed Substudies
Informed Consent
Monitoring
Genomics
Neurology
Arterial Elasticity
Pulmonary
Bone Mineral Density
Liver Fibrosis Progression
Study group
ICC Newsletter
Presentations
Publications
2022
2021
2020
2019
2018
2017
2016
2015
TB:HIV
About
TB:HIV Study Group
Data Collection
Documents
Newsletters
Presentations
Publications
Submit research concept
VACCELERATE
National Coordinators
Report
Completed
CASS Protocol
C. diff
COHERE
ENFORCE
About ENFORCE
Study Governance
Study Group
Study Documents
Study Reports
Publications
Info til deltagere
ESPRIT Trial
About IL-2
Publications
Study Group
EuroCoord
FLU 002 Plus
HA-REACT
HIDES
ICOS Study
INTEGRATE JA
NEAT001
Ancillary & Substudies
Adherence
Bone
Neurocognitive Function
Pharmacoeconomics
Pharmacogenetics
Quality of Life
Renal Function
Viral/Immunologic Dynamics/Inflammation
Viral Subtype
Study Group
Publications
Presentations
Optimizing testing
About
Who to Test
Test af HIV i almen praksis
Testning og tolkning af resultater
Test af HBV og HCV i almen praksis
PASS
Publications
PARTNER
PARTNER 2
Meetings
Conferences
Teleconferences
Newsletters
Participating Sites
Austria
Belgium
Denmark
Finland
France
Germany
Ireland
Italy
Portugal
Spain
Sweden
Switzerland
The Netherlands
UK
Press
Articles and Interviews
Links to media coverage
Recruitment Strategies
Study Documents
General
Danish
Dutch
English
Finnish
Flemish
French
German
Swiss version
Italian
Swiss version
Portuguese
Spanish
Swedish
Informed Consent Forms
Study Group
Publications
Q and A
Final results
Q and A 2018
About
PARTNER press release 2018
ProbeC
SILCAAT trial
Publications
Study Group
SMART Study
About
Map
Presentations
Publications
Study Group
STALWART
About
Newsletters
Publications
Publications
Peer-reviewed
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2006-2011
2000-2005
Reports
Dissertations
Presentations
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2006-2011
2000-2005
PERSIMUNE
Clinical programs
MATCH
Publications
Presentations
Presentations 2015
Presentations 2014
Vaccines
CLASS
SACC
Booklets on hepatitis C
SACC in media
CATCH
Resources
Clinical risk scores
Tools & Standards
CoDe
About
Pilot
Working Group
Documents
CoDe Status
Presentations
Publications
Review
Reviewer FAQ
Methodology
Technical
CoDe Reviewers
HICDEP
Acknowledgements
Documents
Files
Education
EACS online course
IATA training
Infektionsmedicin
Collaborations
INSIGHT
INSIGHT Network
Newsletters
Publications
Presentations
EuroTEST
INTEGRATE JA
Testing Week
HepHIV Conference
OptTEST
European Test Finder
Research
Publications
Peer-reviewed
2024
Peer-reviewed »
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2006-2011
2000-2005
Reports
Dissertations
peer-reviewed Publications 2024
Differences in integrated assessment and management of non-communicable diseases (NCDs) for people with HIV across the WHO European region.
Kraef C, Singh S, Fursa O, Abutidze A, Rukhadze N, Mulabdic V, Yancheva N, Mehmeti M, Balayan T, Harxhi A, Trajanovska J, Mackintosh C, Duvivier C, Beniowski M, Jilich D, Reikvam DH, Tau L, Podlekareva D, Ryom L, Peters L, Kowalska J, Kirk O; EuroSIDA Study Group.
HIV Med. 2024. Epub ahead of print.
Abstract
SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort.
Fursa O, Bannister W, Neesgaard B, Podlekareva D, Kowalska J, Benfield T, Gerstoft J, Reekie J, Rasmussen LD, Aho I, Guaraldi G, Staub T, Miro JM, Laporte JM, Elbirt D, Trofimova T, Sedlacek D, Matulionyte R, Oprea C, Bernasconi E, Hadžiosmanović V, Mocroft A, Peters L; EuroSIDA Study Group.
HIV Med. 2024. Epub ahead of print.
Abstract
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.
Byonanebye DM, Polizzotto MN, Maltez F, Rauch A, Grabmeier-Pfistershammer K, Wit F, De Wit S, Castagna A, d'Arminio Monforte A, Mussini C, Wasmuth JC, Fontas E, Abela I, Sarcletti M, Bansi-Matharu L, Jaschinski N, Peters L, Hosein SR, Vannappagari V, Cohen C, Bissio E, Mocroft A, Law M, Ryom L, Petoumenos K; RESPOND study group.
Lancet HIV. 2024;11(5):e321-e332.
Abstract
Anemia in liver transplant recipients: prevalence, severity, risk factors, and survival.
Hegland NØ, Rezahosseini O, Pedersen CR, Møller DL, Bugge TB, Wareham NE, Arentoft NS, Hillingsø J, Lund TK, Rasmussen A, Nielsen SD.
APMIS. 2024;132(3):152-160.
Abstract
Differences in toll-like receptor ligand-induced cytokine concentrations before and after solid organ transplantation: A prospective, observational cohort study in a clinical setting.
Møller DL, Sørensen SS, Perch M, Gustafsson F, Hald A, Knudsen AD, Abdulovski R, Arentoft NS, Lundgren J, Rasmussen A, Ostrowski SR, Nielsen SD.
Scand J Immunol. 2024;99(2):e13337.
Abstract
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
Jensen TO, Grandits GA, Jain MK, Murray TA, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens RA, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group.
J Infect Dis. 2024;229(3):671-679.
Abstract
ExplaineR: an R package to explain machine learning models.
Zargari Marandi R.
Bioinform Adv. 2024;4(1):vbae049.
Abstract
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants.
Mørup SB, Leung P, Reilly C, Sherman BT, Chang W, Milojevic M, Milinkovic A, Liappis A, Borgwardt L, Petoumenos K, Paredes R, Mistry SS, MacPherson CR, Lundgren J, Helleberg M, Reekie J, Murray DD; INSIGHT FIRST and START study groups.
AIDS Res Ther. 2024;21(1):27.
Abstract
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study.
Clin Infect Dis. 2024:ciae228.
Abstract
Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade.
Søborg A, Reekie J, Sengeløv H, Da Cunha-Bang C, Lund TK, Ekenberg C, Lodding IP, Moestrup KS, Lundgren L, Lundgren JD, Wareham NE.
Eur J Haematol. 2024;112(5):802-809.
Abstract
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.
Pelchen-Matthews A, Mocroft A, Ryom L, Ross MJ, Sharma S, Coca S, Achhra A, Cornell E, Tracy R, Phillips A, Alonso MM, Toulomi G, Agan BK, Medland N, Wyatt CM; INSIGHT START Study Group.
Kidney Int. 2024:S0085-2538(24)00313-2. Epub ahead of print.
Abstract
Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2.
Reekie J, Stovring H, Nielsen H, Johansen IS, Benfield T, Wiese L, Stærke NB, Iversen K, Mustafa AB, Petersen KT, Juhl MR, Knudsen LS, Iversen MB, Andersen SD, Larsen FD, Baerends EAM, Lindvig SO, Rasmussen LD, Madsen LW, Bannister W, Jensen TO, Dietz LL, Ostrowski SR, Østergaard L, Tolstrup M, Lundgren JD, Søgaard OS; ENFORCE study group.
Int J Infect Dis. 2024:107111.
Abstract
The HepHIV 2023 Madrid conference: A call to action for political leadership in reaching the sustainable development goals on earlier testing and linkage to care for HIV, viral hepatitis, and sexually transmitted infections.
Simões D, Raben D, Moran AB, Imaz A, Stengaard AR, Raahauge A, Sullivan AK, Vaughan E, Brännström J, De Baetselier I, Platteau T, Casabona J, Del Amo J; 2023 HepHIV Conference Organising Committee and the EuroTEST Steering Committee.
HIV Med. 2024. Epub ahead of print.
Abstract
All-cause and AIDS-related mortality among people with HIV across Europe from 2001 – 2020: impact of antiretroviral therapy, and regional differences in a multicentre cohort study
Kraef C, Tusch E, Singh S, Østergaard L, Fätkenheuer G, Castagna A, Moreno S, Kusejko K, Szetela B, Kuznetsova A, Tomažič J, Ranin J, Zangerle R, Mansson F, Marchetti G, De Wit S, Clarke A, Gerstoft J, Podlekareva D, Peters L, Reekie J, Kirk O, and the EuroSIDA Study Group.
The Lancet Regional Health - Europe 2024;44: 100989.
Abstract
Chronic liver enzyme elevation and use of contemporary ARVs among persons living with HIV.
Roen AO, Peters L, Wandeler G, van der Valk M, Zangerle R, Günthard HF, Wit F, Mussini C, De Wit S, d’Arminio Monforte A, Vehreschild JJ, Castagna A, Jaschinski N, Vannappagari V, Chen L, Tallada J, C’mar J, Mocroft A, Ryom L.
Open Forum Infectious Diseases, 2024;11(6): ofae308.
Abstract
Are C-reactive protein and procalcitonin safe and useful for antimicrobial stewardship purposes in patients with COVID-19? A scoping review.
Williams A, Repetto E, Lebbie I, Khalife M, Jensen TO.
Antimicrob Steward Healthc Epidemiol. 2024;4(1):e129.
Abstract
Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.
Hutchinson J, Neesgard B, Kowalska J, Grabmeier-Pfistershammer K, Johnson M, Kusejko K, De Wit S, Wit F, Mussini C, Castagna A, Stecher M, Pradier C, Domingo P, Carlander C, Wasmuth J, Chkhartishvili N, Uzdaviniene V, Haberl A, d'Arminio Monforte A, Garges H, Gallant J, Said M, Schmied B, van der Valk M, Konopnicki D, Jaschinski N, Mocroft A, Greenberg L, Burns F, Ryom L, Petoumenos K.
HIV Med. 2024. Epub ahead of print.
Abstract
Deep immune cell phenotyping and induced immune cell responses at admission stratified by BMI in patients hospitalized with COVID-19: An observational multicenter cohort pilot study.
Sejdic A, Hartling HJ, Gitz Holler J, Klingen Gjærde L, Matovu Dungu A, Engel Møller ME, Svanberg Teglgaard R, Utoft Niemann CU, Brooks PT, Mogensen TH, Weis N, Podlekareva D, Baum Jørgensen ML, Ortved Gang A, Stampe Hersby D, Hald A, Dam Nielsen S, Lebech AM, Helleberg M, Lundgren J, Træholt Franck K, Fischer TK, Barrella Harboe Z, Marquart HV, Rye Ostrowski S, Lindegaard B.
Clin Immunol. 2024;267:110336.
Abstract
Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation.
Minculescu L, Reekie J, Petersen SL, Kornblit BT, Schjoedt I, Andersen NS, Andersen LP, Fischer-Nielsen A, Haastrup EK, Friis LS, Sengelov H.
Acta Haematol. 2024;147(3):325-332.
Abstract
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
Chou S, Alain S, Cervera C, Chemaly RF, Kotton CN, Lundgren J, Papanicolaou GA, Pereira MR, Wu JJ, Murray RA, Buss NE, Fournier M.
J Infect Dis. 2024;229(2):413-421.
Abstract
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Jensen TO, Murray TA, Grandits GA, Jain MK, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens R, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group.
Lancet Microbe. 2024;5(6):e559-e569.
Abstract
Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19.
Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, Chia PY, Davis R, Files C, Ginde AA, Hatlen T, Helleberg M, Hayanga A, Jensen TO, Jain MK, Kalomenidis I, Kim K, Lallemand P, Lindegaard B, Menon A, Ognenovska K, Poulakou G, Thorup Røge B, Rogers AJ, Shaw-Saliba K, Sandkovsky U, Trautner BW, Vasudeva SS, Vekstein A, Viens K, Wyncoll J, DuChateau B, Zhang Z, Wu S, Babiker AG, Davey V, Gelijns A, Higgs E, Kan V, Lundgren J, Matthews GV, Lane HC.
J Infect Dis. 2024:jiae452. Epub ahead of print.
Abstract
Impact of baseline SARS-CoV-2 load in plasma and upper airways on the incidence of acute extrapulmonary complications of COVID-19: a multicentric, prospective, cohort study.
Jensen TO, Harper K, Gupta S, Liu ST, Dharan NJ, Baker JV, Pett SL, Shaw-Saliba K, Esmail A, Ho MQ, Almasri E, Dewar RL, Lundgren J, Vock DM.
Clin Infect Dis. 2024:ciae469.
Abstract
Integrase strand transfer inhibitor (INSTI) related changes in BMI and risk of diabetes: a prospective study from the RESPOND cohort consortium.
Rupasinghe D, Bansi-Matharu L, Law M, Zangerle R, Rauch A, Tarr PE, Greenberg L, Neesgaard B, Jaschinski N, De Wit S, Wit F, Monforte AD, Fontas E, Castagna A, Stecher M, Brandes V, Florence E, Begovac J, Mussini C, Sönnerborg A, Abutidze A, Groh A, Vannappagari V, Cohen C, Young L, Hosein S, Ryom L, Petoumenos K.
Clin Infect Dis. 2024:ciae406.
Abstract
Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and Infection.
Juhl AK, Dietz LL, Søgaard OS, Reekie J, Nielsen H, Johansen IS, Benfield T, Wiese L, Stærke NB, Jensen TØ, Olesen R, Iversen K, Fogh K, Bodilsen J, Madsen LW, Lindvig SO, Raben D, Andersen SD, Hvidt AK, Andreasen SR, Baerends EAM, Lundgren J, Østergaard L, Tolstrup M; ENFORCE Study Group.
J Infect Dis. 2024;230(3):e605-e615.
Abstract
Longitudinal Importance of the Soluble Receptor for Advanced Glycation End-Products in Non-intubated Hospitalized Patients with COVID-19 Pneumonia.
Wick KD, Siegel L, Oldmixon C, Lundgren JD, Thompson BT, Jones C, Leroux C, Matthay MA.
Am J Physiol Lung Cell Mol Physiol. 2024. Epub ahead of print.
Abstract
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.
Cozzi-Lepri A, Dunn D, Tostevin A, Marvig RL, Bennedbaek M, Sharma S, Kozal MJ, Gompels M, Pinto AN, Lundgren J, Baxter JD; INSIGHT START Study Group.
HIV Med. 2024;25(2):212-222.
Abstract
Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in Europe.
Johansen IS, Roen A, Kraef C, Martín-Iguacel R, Nemeth J, Fenner L, Zangerle R, Llibre JM, Miller RF, Suarez I, de Wit S, Wit F, Mussini C, Saracino A, Canetti D, Volny-Anne A, Jaschinski N, Neesgaard B, Ryom L, Peters L, Garges HP, Rooney JF, Podlekareva D, Mocroft A, Kirk O; RESPOND Study group.
Int J Infect Dis. 2024;147:107199.
Abstract
The use and impact of European Testing Week regional awareness campaigns to increase HIV and viral hepatitis testing coverage.
Raben D, Kahama CB, Combs L, Stengaard A, Rockstroh JK, Simões D, Collins B; European Testing Week Working Group and the EuroTEST Steering Committee.
HIV Med. 2024;25(1):154-160.
Abstract
Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade.
Søborg A, Reekie J, Sengeløv H, Da Cunha-Bang C, Lund TK, Ekenberg C, Lodding IP, Moestrup KS, Lundgren L, Lundgren JD, Wareham NE.
Eur J Haematol. 2024;112(5):802-809.
Abstract
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
Aggarwal NR, Nordwall J, Braun DL, Chung L, Coslet J, Der T, Eriobu N, Ginde AA, Hayanga AJ, Highbarger H, Holodniy M, Horcajada JP, Jain MK, Kim K, Laverdure S, Lundgren J, Natarajan V, Nguyen HH, Pett SL, Phillips A, Poulakou G, Price DA, Robinson P, Rogers AJ, Sandkovsky U, Shaw-Saliba K, Sturek JM, Trautner BW, Waters M, Reilly C; ACTIV-3/TICO Study Group.
Clin Infect Dis. 2024;78(6):1490-1503.
Abstract
Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics.
Salmanton-García J, Wipfler P, Leckler J, Nauclér P, Mallon PW, Bruijning-Verhagen PCJL, Schmitt HJ, Bethe U, Olesen OF, Stewart FA, Albus K, Cornely OA; VACCELERATE Consortium.
Travel Med Infect Dis. 2024;57:102676.
Abstract
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Clifford Lane H, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members.
J Infect Dis. 2024;230(3):624-634.
Abstract
IN PRESS